Blood glucose meters
There's a new agreement for funding blood glucose meters and test strips until 2022.
2012 - First sole-supply procurement
In 2012 PHARMAC moved to sole supply of blood glucose meters and testing strips, which are mainly used by people with diabetes to test their blood sugar levels.
The price reduction from changing to sole supply of the CareSens range of meters and strips meant savings of $10 million per year compared to previous spending, that can be used to fund other medicines.
2015 - Consultation on the sole supply approach
In March 2015 PHARMAC released a consultation document that looked at the future funding approach to blood glucose meters and test strips. The consultation provided information and asked questions to help inform PHARMAC’s approach for the funding of blood glucose meters and test strips.
PHARMAC received 313 individual responses to the consultation from consumers, consumer groups, health professionals and suppliers of blood glucose meters and test strips. People provided us with lots of different feedback and opinions on the questions and proposed approach.
2015 to 2017 - Second sole-supply procurement
- Invitation for expressions of interest for the supply of diabetes management products
- Request for proposals: Supply of funded diabetes management products
- Consultation: Diabetes management products - proposal for five-years' sole supply for CareSens blood glucose and ketone meters and test strips
- Notification: Diabetes management products
Last updated: 2 August 2018